These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34576273)

  • 1. Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages.
    Lagies S; Pichler R; Vladimirov G; Gawron J; Bäzner F; Schreiner A; Kadena D; Plattner DA; Lienkamp SS; Kammerer B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolomics study of vancomycin-associated nephrotoxicity based on ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.
    Cao P; Kang Y; Liu J; Liu X; Jin Y; Zhang Z
    Hum Exp Toxicol; 2022; 41():9603271221119178. PubMed ID: 35984423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
    Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J
    Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the vancomycin-induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling.
    Du H; Li Z; Yang Y; Li X; Wei Y; Lin Y; Zhuang X
    J Appl Toxicol; 2020 Jul; 40(7):897-907. PubMed ID: 32079046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
    Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
    J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice.
    Takigawa M; Yatsu T; Takino Y; Matsumoto S; Kitano T; Lee J; Arai T; Tanaka H; Ishii T; Mori Y; Ishigami A
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(5):399-404. PubMed ID: 31666476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
    Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
    Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Ogino T; Inoue M; Okada S; Kinoshita H
    Free Radic Res; 2003 Apr; 37(4):373-9. PubMed ID: 12747731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-Analysis.
    Fiorito TM; Luther MK; Dennehy PH; LaPlante KL; Matson KL
    Pediatr Infect Dis J; 2018 Jul; 37(7):654-661. PubMed ID: 29280786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus methicillin resistance detected by HPLC-MS/MS targeted metabolic profiling.
    Schelli K; Rutowski J; Roubidoux J; Zhu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():124-130. PubMed ID: 27316783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Alvarez CA; Giuliano CA; Haase KK; Thompson KA; Frei CR; Forcade NA; Brouse SD; Mortensen EM; Bell T; Bedimo RJ; Toups NM; Hall RG
    Am J Med Sci; 2014 Nov; 348(5):371-6. PubMed ID: 24762747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity Profile and Pharmacokinetic Study of Antibiotic Mixtures, Gentamicin and Vancomycin, in Rat Plasma by Ecofriendly Liquid Chromatography Coupled Tandem Mass Spectrometry.
    Ibrahim F; Elgawish MS; Mehana E; El-Adl SM; Baraka MM; Ibrahim SM; Sebaiy MM
    Chem Res Toxicol; 2020 Oct; 33(10):2647-2658. PubMed ID: 32940458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.
    Haste NM; Thienphrapa W; Tran DN; Loesgen S; Sun P; Nam SJ; Jensen PR; Fenical W; Sakoulas G; Nizet V; Hensler ME
    J Antibiot (Tokyo); 2012 Dec; 65(12):593-8. PubMed ID: 23047246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin versus vancomycin for proven or suspected infection.
    Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat.
    Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Tanaka H; Inoue M; Okada S; Kinoshita H
    Redox Rep; 2002; 7(5):317-9. PubMed ID: 12688519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.